Vimedimex Medi Pharma JSC
Vimedimex Medi-Pharma Joint Stock Company engages in the pharmaceutical distribution business in Vietnam. The company provides imported drugs, domestic medicines, medical supplies, family medical equipment, healthcare instruments, and functional foods; and leasing of office buildings and warehouses. It also offers prescription drugs, supplements, medical equipment, cosmetics, and mother and baby … Read more
Vimedimex Medi Pharma JSC (VMD) - Net Assets
Latest net assets as of : ₫- VND
Based on the latest financial reports, Vimedimex Medi Pharma JSC (VMD) has net assets worth ₫- VND as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₫-) and total liabilities (₫-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₫- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Vimedimex Medi Pharma JSC - Net Assets Trend (None–None)
This chart illustrates how Vimedimex Medi Pharma JSC's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Vimedimex Medi Pharma JSC (None–None)
The table below shows the annual net assets of Vimedimex Medi Pharma JSC from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Vimedimex Medi Pharma JSC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Vimedimex Medi Pharma JSC Competitors by Market Cap
The table below lists competitors of Vimedimex Medi Pharma JSC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
WW GRAINGER - Dusseldorf Stock Exchang
DU:GWW
|
$9.35 Million |
|
Phuc Hung Holdings Construction JSC
VN:PHC
|
$9.35 Million |
|
MONGOLIA ENERG. HD-02
F:NWW
|
$9.35 Million |
|
KBC Global Limited
NSE:KBCGLOBAL
|
$9.35 Million |
|
Scandinavian Enviro Systems AB
ST:SES
|
$9.34 Million |
|
MALT. FR.-BELGES
F:91U
|
$9.33 Million |
|
Pansar Bhd
KLSE:8419
|
$9.33 Million |
|
Mercan Kimya Sanayi ve Ticaret AS
IS:MERCN
|
$9.33 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Vimedimex Medi Pharma JSC's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Vimedimex Medi Pharma JSC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Vimedimex Medi Pharma JSC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Vimedimex Medi Pharma JSC's net assets metrics with peer companies in the Biotechnology industry.
No peer company data available for comparison.